The Trump administration is preparing a proposal that will likely peg what Medicare pays for prescription drugs to prices in other nations.
Name brand drugs generally cost less abroad because foreign governments forcibly control their prices. So this international price index would effectively import those foreign price controls.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.